http://www.fool.com/News/mft/2006/mft06072119.htm?ref=btpGilead's Acquisitive MoodBy Brian Lawler July 21, 2006 With the Nasdaq biotech index down 13% for 2006, most biotech investors are having a bad year. Not so for investors in Gilead Sciences (Nasdaq: GILD); shares of the biopharmaceutical company have risen more than 9% since the year began.Yesterday, Gilead released results from its busy and acquisitive second quarter. Just last month, the company purchased a manufacturing facility for $144 million. Two days ago, Gilead announced its purchase of the remaining shares of privately held Corus Pharmaceuticals for $365 million.....
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat